Gentex Corporation
boothcheck covers Gentex Corporation (GNTX) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed June 27, 2026.
- At about $25.95 the price is supported by every valuation family rather than resting on a single bet. The asset and earnings-power methods land in the high teens to mid twenties, the residual-income method lands almost exactly on the price, and the growth and relative methods land higher, near $40 to $63. - The balance sheet is unusually clean: roughly $171 million of net cash, essentially no debt, and a share count shrinking at about 2% a year through buybacks, which gives management room to
Is GNTX overvalued? See what's priced in →
488 institutional managers reported holding GNTX in 13F filings for the quarter ended 2026-03-31. Together they hold about 93% of the company; the top 10 hold 49%. 58 opened new positions that quarter. Held by Vanguard Group, BlackRock, Dimensional Fund Advisors, among others. On the short side, 14.8M shares were sold short as of the 2026-06-15 count, about 7% of shares outstanding (6.4 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
GNTX has cut its share count 11.4% over the past five years, spending $961.21M on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting); the current rate is $0.48 a share annually. Cash returned over the past three years: $299.15M in dividends and $683.46M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at GNTX over the trailing three years. Absence is a fact about the company, not a signal. 13 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
GNTX's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-05-05 | +4.8% | +6.7% |
| 2023-08-04 | +3.6% | -6.1% |
| 2023-11-04 | -7.4% | +5.6% |
| 2024-02-23 | +6.5% | -3.8% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
GNTX's latest 8-K filings: 2026-07-24 (items 2.02, 9.01); 2026-05-26 (items 5.07); 2026-04-24 (items 2.02, 9.01); 2026-01-30 (items 2.02, 9.01); 2025-10-24 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.